Nature's Sunshine Products (NATR) investor relations material

Market overview and growth trends

• Operates in the $1.1 trillion global nutritional supplements market, projected to grow at a 7.1% CAGR from 2025–2029, up from 4% CAGR in 2022–2024.

• U.S. supplement market reached $69.3 billion in 2024.

• Health and wellness, energy, gut health, and immunity are top consumer priorities.

• Direct selling is a $160B global industry with 100M participants; gig and affiliate models are rapidly expanding.

Business model and product portfolio

• Multi-channel approach: direct-to-consumer, specialty retail, health practitioners, and independent consultants.

• Two global brands with a diverse portfolio covering digestive, general health, cardiovascular, immune, sports/energy, and weight management needs.

• Manufactures 90% of products in-house, with rigorous quality controls and certifications (FDA, ISO, NSF, USDA Organic, Halal, TGA).

• Vertically integrated with in-house R&D and excess production capacity.

Financial performance and guidance

• 2025 sales and EBITDA projected at $480M and $49M, with a 2022–2025 CAGR of 5% for sales and 21% for EBITDA.

• Zero-debt balance sheet and strong capital discipline.

• FY 2026 guidance: $500–$515M net sales and $50–$54M adjusted EBITDA.

• Outperformed peers in revenue and EBITDA growth; total shareholder return of 210% since Jan 2023.